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BESREDKA'S "ANTIVIRUS" IN RELATION TO




Alexander Fleming's initial views on the nature and clinical use ofpenicillin have
recently evoked a considerable amount ofspeculation.' It is clear that Fleming made
a number of attempts to use crude penicillin (i.e., filtrates ofcultures of Penicillium
notatum) on surface wounds during the brief period following his chance
discovery of the substance in September 1928.2 He also enlisted the help of a
number of students and others in attempts to extract the active ingredient from the
crude meat broths on which his penicillin-producing isolate grew. Although Lewis
Holt used solvent transfer for the purification ofpenicillin in 1934,3 Fleming, with his
limited knowledge of chemistry, did not appreciate the importance of this. Harold
Raistrick's inability to isolate penicillin in the early 1930s no doubt increased
Fleming's sense of the impossibility of the task.4 However, it seems that his own
experiments had by that time convinced him that penicillin would be quickly
inactivated when injected into the bloodstream, and that even ifpurified, it would be
of limited medical use.5 Fleming did not discard penicillin altogether, but put it to
good use as a component ofselective bacterial culture media. There is also anecdotal
evidence that he persisted with the view that it might one day find a use in medicine.
For example, he is said to have commented to Douglas McLeod on leaving a talk on
sulphonamides given by Gerhard Domagk in London in 1935 that in penicillin6 he
had something much better than Prontosil, but nobody was interested and he was
unable to find a chemist who would take the trouble to isolate this substance for him.
My aim in this paper is to show that soon after discovering penicillin, Fleming's
thoughts on the nature ofpenicillin were markedly altered by Besredka's "antivirus",
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which was then enjoying something ofa vogue. While in 1929 he considered penicillin
to be what was later termed an antibiotic, by 1931 he was regarding it as a form of
antivirus; it was this change, helped by some discouraging laboratory results, which
deflected him from considering penicillin as a potentially important therapeutic
agent.
BESREDKA S "ANTIVIRUS"
The modern reader might expect that the term "antivirus" would describe a
substance capable of inhibiting viruses and thereby possibly curing viral infections.
However, the French bacteriologist and immunologist Alexandre Besredka used the
term during the 1920s to describe a novel approach to the treatment of bacterial
infections.7 Besredka (1870-1940) was born in Odessa, Russia and went to Paris with
Elie Metchnikoff as a preparateur. He became Director of the Pasteur Institute on
Metchnikoff's death and it was there that he developed his antivirus therapy. This
involved applying to wounds or surface infections a filtered broth on which bacteria
had grown to exhaustion. This broth was said to contain the antivirus, which was
regarded as host specific; that is, staphylococcal, but not for example streptococcal
infections, were healed with filtrate ofbroth on which staphylococci had been grown.
The broth filtrate was protein-free, and the antivirus was heat-stable to 100-1 15C.
Besredka believed that the beneficial effects ofhis antivirus resulted from a change in
localized immunity in the cells treated with the filtrates, and that any antibacterial
effects were purely accidental and secondary.8 He was careful to distance himself
from the idea that his broths were necessarily "a bad medium for the culture oftheir
respective bacteria". Hetherefore objected to the viewthat the activity ofhis antivirus
wasdue totheproduction bybacteria ofsuchantibacterial agents as pyocyanase; nor,
in his opinion, were the effects due to staling of bacterial cultures resulting from
exhaustion of the growth medium.
Besredka's antivirus therapy was widely used in the 1920s and early 1930s,
particularly in continental European countries. Dressings immersed in bacterial
filtrates were said to be effective in the treatment of boils, osteomyelitis, and even
anthrax. Agar on which bacteria had grown was apparently equally successful.9
Antivirus therapy was not without its critics; some concluded that it was the mere
act of filtration which conferred the immunizing effects on the broths, and others
disputed Besredka's view that his antivirus conferred a specific immunity. Thus
Frederick Gay,'0 among others, while accepting that antivirus therapy was effective,
nevertheless concluded that it was non-specific and that even plain bacteriological
broth could cause the local proliferation of the macrophages that actually provided
the remarkable protective value of antivirus against virulent localized streptococcal
infections.
7 A. Besredka, Local immunisation, specific dressings, Baltimore, Williams & Wilkins, 1927.
8 Idem, 'Are antiviruses specific?', J. Immun., 1932, 23: 349-60.
9 H.Jussion, M.Vaucel, and E. Diot,'Agarvaccines inskininfections', Pressemed., Paris, 1926, 1: 642-5.
10 F. P. Gay, 'The recent hypothesis ofBesredka', in The newknowledge ofbacteriology andimmunology,
ed. E. 0. Jordan and I. S. Falk, University of Chicago Press, 1928, pp. 884-90.
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WAS ANTIVIRUS THERAPY SUCCESSFUL?
A large number of reports in the medical literature of the 1920s and early 1930s
suggest that, although arguments might be raised against the theory of antivirus
therapy, in practice it was an extremely effective means of treating bacterial
infections, both in animals and man. Ernst Oesterlin,'1 for example, concluded that
the therapeutic benefits ofthis treatment had been proved to be effective not only in
France, but also in Austria and Germany.
An excellent example ofa reported cure using antivirus is provided in a report by
Alfred Merten and Oesterlin,12 who used antivirus in the treatment of malignant
oedema caused by Clostridium (i.e., gas gangrene). While working at the pathology
laboratory of the Milwaukee Hospital they reported, in 1932, the case of a
12-year-old boy who had fallen from a tree and whose radius of the right arm
protruded some two and a halfinches. The fracture was operated upon and a splint
applied. On the following day his temperature rose to 103°F and on the third day the
arm was reported as swollen and emitting an offensive odour. Some four weeks after
the accident, and despite extensive conventional treatment, the arm was still swollen
and gas bubbles continued to issue from the wound. On the twenty-eighth day
Oesterlin applied the antivirus to the wound, using a soaked dressing. The antivirus
was prepared by inoculating a broth culture with Clostridium in a flask, overlaying it
with liquid paraffln and incubating it for eight days. The broth was then filtered and
heated to 100°C for five minutes.
Within two hours of the application of the antivirus to the wound, the boy's
temperature rose to 101.4°F. It fell to normal within the next forty-eight hours. On
the eighth day of the treatment, the wound showed definite signs of healing and no
gas evolution was apparent. The young boy was allowed home seven weeks after the
accident. Merten and Oesterlin ended their report by stating that, "while the
anatomic result in this case is not all that could be desired, the boy has a functional
hand, and not an artificial appliance", and they concluded that antivirus treatment
had been the major factor in saving the hand.
Antivirus was even produced on a commercial scale. Allen and Hanbury, Vere
Street, London, for example, advertised an antivirus in the Medical Annual of 1926,13
advising customers that after a bacteriological examination, antivirus could be
prepared for local application to infections of the skin, genito-urinary passages,
nose, mouth, and throat. The same year the Leeds firm of Reynolds and Branson
advertised, in the same journal, a staphylococcal acne bacillus filtrate (not directly
referred to as an antivirus) which they claimed could be successfully applied to the
skin for the treatment ofacne and some forms ofeczema.14 Finally Roberts and Co.
of New Bond Street, London advertised in 1930 a substance called "Antivirus
Bi-Ro", prepared by a Paris-based company, La Biotherapie.'5 This product was a
mixed streptococcal-staphylococcal antivirus, recommended for application to burns
IIE. J. Oesterlin, 'Experimental studies with pyocyaneus filtrates', J. Immun., 1929, 16: 359-67.
12 A. N. E. Merten and E. J. Oesterlin, 'Antivirus treatment ofmalignant oedema infections', Ann. Surg.,
1932, 95: 101-5.
13 [Anon.], 'Antivirus', Med. Ann., 1926, p. 532.
14 [Anon.], 'Staphylococcus acne bacillus filtrate', ibid., p. 536.
15 [Anon.], 'Antivirus Bi-ro', ibid., 1930, p. 570.
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or wounds. Again, purchasers had to specify the type of bacteria which had caused
the infection they hoped to treat. By the early 1930s, then, there was a small, if
growing, commercial supply ofantivirus.16
BESREDKA S ANTIVIRUS AND FLEMING S INITIAL VIEWS ON PENICILLIN
On 15 May 1929 a paper giving details of Besredka's ideas about antivirus was
communicated to the Royal Society of Medicine by Dr Broughton Alcock.17
Besredka was prevented by a bad cold from giving the paper in person, which was
unfortunate because it came in for considerable criticism that would have been
effectively addressed only by Besredka. Thepaperwas the subject ofeditorials in both
the British MedicalJournall8 and theLancet,19 which, while recognizing the potential
importance ofthe antivirus therapy, nevertheless maintained the critical atmosphere
which surrounded Besredka's views in England.
The British Medical Journal editorial elicited some response from readers on the
subject ofantivirus. A. G. Buchanan from Johannesburg testified to the usefulness of
bacterial filtrates in fighting infections, but concluded that Besredka's idea of the
involvement of a localized immunity was unhelpful.20 R. F. Hunwick2' also
commented on how useful antivirus therapy could be, but regarded its success as the
result ofthefiltrates' ability toinhibit thegrowth ofpathogenic bacteria. Hisviews on
the action ofantivirus were therefore closer to the modern idea ofantibiosis than was
Besredka's concept of localized immunity.
Fleming attended this meeting in London, and his comments on antivirus were
recorded at length in the Proceedings of the Royal Society of Medicine.22 He had
discovered penicillin only nine months before and had already submitted his famous
first paper on penicillin, which arrived on the desk ofthe editor ofthe British Journal
of Experimental Pathology and Bacteriology five days before the meeting, on 10
May.23
Fleming's initial response to the Besredka paper was on the whole critical and, like
other contributors to the discussion, he found it difficult to know exactly what
Besredka meant by "antivirus". A number ofFleming's comments are worth quoting
in full, especially since he referred to penicillin and in comparing its properties with
those of antivirus gives us a unique insight into his view of the nature of penicillin
soon after its discovery.
The first relevant comment is,
In this paper he [Besredka] relies in the main on clinical reports ofcases treated by
various physicians, male and female, and not under his own supervision; favourable
clinical reports can easily be obtained for almost any method of treatment.
16[Anon.], 'Gonococcal antivirus', ibid., pp. 262-3.
17 A. Besredka, 'Antivirus therapy in infectious diseases', Proc. R. Soc. Med., 1929, 22: 1579-98.
18 [Anon.], 'Antivirus therapy', Br. Med. J., 1929, i: 955-6.
19 [Anon.], 'The antivirus of Besredka', Lancet, 1929, 1:1157.
20 G. Buchanan, 'Bacterial filtrates or antivirus therapy', letter, Br. Med. J., 1929, ii: 324.
21 R. F. Hunwick, 'Antivirus therapy', letter, ibid., i: 1100.
22 Besredka, op. cit., note 17 above.
23 Fleming, op. cit., note 2 above.
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This statement is particularly interesting because at that time Fleming was probably
involved in attempts to use penicillin to treat surface infections and wounds. Even
had he achieved occasional clinical successes with crude penicillin, he would not
necessarily have laid great stress upon these results since they would be no more nor
less than could be obtained "for almost any method of treatment". This, no doubt
correct, attitude to the occasional successful outcome ofa novel therapy may explain
why both Fleming and Cecil G. Paine failed to continue their therapeutic studies on
crude penicillin, which in hindsight would appear to have been promising.24
Fleming then referred to penicillin.
Recently I have been making some observations on somewhat similar lines. I found
that when a particular mould had been grown in broth for a week or ten days, the
filtrate of the culture had remarkable inhibitory properties on the growth of some
microbes, especially the pyogenic cocci. This filtrate, like Besredka's antivirus,
consists of nutrient broth, except that instead of being exhausted by a bacterium it
has supported the growth of a mould for some time (not to exhaustion).
In this statement Fleming successfully summarized his recent work on penicillin,
which he contrasted with antivirus as a broth obtained by growing a culture, but not
to exhaustion. He had earlier pointed out that the inhibitory power of such
exhausted broths had frequently been demonstrated, a phenomenon which he said
could be due "either to the exhaustion of the broth in regard to some foodstuff
necessary to the growth of the particular microbe, or to the accumulation of waste
products which inhibited further growth".
Fleming continued his reference to penicillin,
I have applied this filtrate to a number of septic wounds (abscesses, burns, ulcers
etc.), and so far the results are certainly not inferior to the cases cited by Besredka.
One patient treated during the last ten days is interesting. A woman had indolent
ulcers in various parts ofthe body. These ulcers had existed for over two months and
showed little signs of healing. The infecting agents in each case were staphylococci
and streptococci. The filtrate was applied in compresses every four hours, and in
three or four days the aspect ofthe ulcers completely changed; they became healthy
looking, granulations formed and healing commenced and is progressing rapidly.
Here we have the first description of a penicillin cure, which would have been
achieved by Fleming around 19 May 1929. It is, however, as yet unsubstantiated by
case notes (which may exist at St Mary's Hospital, Paddington). He almost certainly
worked with Arthur Dickson Wright, who referred to his collaboration with
Fleming on the therapeutic applications of penicillin in 1945.25 That they worked
together was also stated by Almroth Wright in a discussion of a paper read by
Dickson Wright to the Medical Society ofLondon, 1931.26 This paper dealt with the
treatment of indolent ulcers of the leg, on which Dickson Wright was a recognized
24 M. Wainwright and H. T. Swan, 'C. G. Paine and the earliest surviving clinical records of penicillin
therapy', Med. Hist., 1986, 30: 42-56.
25 A. Fleming, 'The uses and limitations ofpenicillin', Trans. Med. Soc. Lond., 1945, 64: 147.
26 A. Dickson Wright, 'The treatment of indolent ulcer of the leg', ibid., 1931, 54: 237-51.
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authority. Despite its considerable length, it gives no reference to penicillin in the
treatment of indolent ulcers. Either the penicillin work was less promising than
Fleming suggested or, perhaps, Dickson Wright considered it to be too preliminary
to be included in this review.
In concluding his comparison of penicillin and Besredka's antivirus, Fleming
wrote,
Here I would point out that in the mould filtrate there was no question of specific
immunity; there was nothing in the preparation specific to staphylococci or
streptococci, but it was simply broth in which a mould had been grown. I therefore
venture to suggest that the improvement in many ofthe cases sited by Besredka need
not have any relation to a specific immunizatory process, and that the term "local
immunity" is the wrong one to apply.
In this final statement Fleming clearly distanced himself from the view that
penicillin's curative effect on indolent ulcers, for example, was due to the induction
ofa localized immunity. One is therefore left with the clear impression that Fleming
considered that penicillin was effective by virtue of its ability to kill the pathogenic
bacteria involved, although this is not stated outright.
Although Fleming clearly contrasted penicillin and Besredka's antivirus, he also
noted a number of similarities. Anyone who took an interest in penicillin could,
from that point on, have dismissed it as a variant ofantivirus, a concept which had
come in for considerable criticism, bordering on downright disbelief.
It is clear that in May 1929 Fleming saw penicillin as a possible therapeutic agent,
although one limited to external use. Any successes he achieved with crude penicillin
he thought were due to the antibacterial activity of the filtrate, rather than to the
induction ofa localized immunity. So, at this time, Fleming seems to have regarded
penicillin as what we would now term an antibiotic. However, in 1931, he dismissed
the idea that a substance would be found which would act as a "universal germicide"
when put into the bloodstream.27 Fleming's pessimism about finding a universal
germicide which would be effective when injected into the bloodstream was by no
means unusual in medical circles during the 1930s. B. S. Levine,28 for example,
probably gave the standard view on this subject in a paper published in the Journal
of Laboratory and Clinical Medicine (1930-31), when he stated that, "The
intravenous method of therapeutic application is much more difficult to approach
[than surface application]. In fact it has been found that no matter what the outcome
of in vitro experiments the intravenous method may result in failure." It was not
until the successful intravenous use of Prontosil in the mid-1930s that medical
opinion on this point underwent a radical change.
While Fleming's initial view of penicillin seems to have approached the modem
concept ofan antibiotic, he had apparently undergone a complete change ofmind by
the time his second penicillin paper appeared in the Journal of Pathology and
27[Anon.], 'Intravenous use ofgermicides', Lancet, 1931, i: 349-51.
28 B. S. Levine, 'Testing the efficiency of bactericidal and bacteriostatic reagents for use in specific
chemotherapeusis', J. Lab. clin. Med., 1930-1, 16: 52-8.
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Bacteriology in 1931.29 In it, he again made a fleeting reference to the use of crude
penicillin as a dressing for indolent septic wounds, and then he wrote, "It is unlikely
that it [penicillin] acts by killing bacteria directly." He continued,
Gratia (1923) and others have shown that when compresses of broth are applied to
the skin there is an aggregation of phagocytic cells in the deeper layers and he has
thus explained the rationale of Besredka's antivirus treatment. Penicillin might then
act in the same way as antivirus but is superior to ordinary [my italics] antivirus in
that it inhibits the growth of not only one but all the pyogenic cocci.
No longer did Fleming regard penicillin as an antibiotic, but as a definite variant of
Besredka's antivirus which does not act by killing bacteria directly, but "by
promoting the aggregation of phagocytes which then deal with the pathogenic
bacteria".
He concluded this section of his second paper with an explanation for his failure
to pursue his clinical studies with penicillin: "The practical difficulty in the use of
penicillin for dressings of septic wounds is the amount of trouble necessary for its
preparation and the difficulty of maintaining its potency for more than a few
weeks."
Fleming did not abandon the idea that penicillin might be used in medicine.
Further attempts were made during the early 1930s to purify penicillin, both by
Raistrick's team and at St Mary's. Although Fleming may have been deflected by
Besredka's antivirus from the true nature of penicillin, this should not detract from
the fact that he discovered the substance and tried to use it in medicine.
By the time Howard Florey and Ernst Chain came to look at penicillin in 1938,
the whole climate of medical opinion had been altered by the appearance of the
sulphonamides, and Besredka's antivirus, if not discredited, had become an
anachronism.
Many of the supposed antibacterial agents developed in the 1930s have now
fallen into oblivion. Some have recently been re-evaluated, among them
bacteriotherapy, maggot therapy, and bacteriophage therapy. Perhaps it is an
opportune moment, then, to re-evaluate the effectiveness ofBesredka's antivirus, for
which many hundreds of cures were claimed.
29 A. Fleming, 'On specific antibacterial properties ofpenicillin and potassium tellurite', J. Path. Bact.,
1932, 35: 831-42.
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